Solventum Corporation (SOLV)
SOLV Energy: The Pullback Makes The Buy Case Stronger
SOLV Energy remains a Buy as the backlog converts into higher-margin earnings, and the stock trades at a compelling valuation discount. MWH's $8.2B backlog and 1.2x book-to-bill offer strong near-term revenue visibility, with O&M and lifecycle services expanding long-term runway. The RWE acquisition strengthens MWH's grid-adjacent capabilities, enabling deeper customer relationships and a greater share of project spend.
Why Solventum (SOLV) is a Top Stock for the Long-Term
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Earnings Growth & Price Strength Make Solventum (SOLV) a Stock to Watch
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Solventum Trends for 2026: AI Coding, Tariffs, and Margins
SOLV heads into 2026 balancing AI coding growth, cost savings, tariff pressure and a potential 2027 margin risk tied to its 3M supply deal.
SOLV Energy, Inc. (MWH) Q1 2026 Earnings Call Transcript
SOLV Energy, Inc. (MWH) Q1 2026 Earnings Call Transcript
SOLV or HQY: Which Is the Better Value Stock Right Now?
Investors interested in Medical Services stocks are likely familiar with Solventum (SOLV) and HealthEquity (HQY). But which of these two stocks offers value investors a better bang for their buck right now?
Solventum Corporation (SOLV) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Solventum Corporation (SOLV) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Solventum (SOLV) Recently Broke Out Above the 200-Day Moving Average
Solventum (SOLV) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, SOLV broke through the 200-day moving average, which suggests a long-term bullish trend.
Why Solventum (SOLV) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Solventum Stock Down Despite Q1 Earnings & Revenues Beat Estimates
SOLV beats Q1 earnings and revenue estimates as growth in MedSurg, Dental and HIS offset sales decline and margin pressure.
Solventum (SOLV) Recently Broke Out Above the 20-Day Moving Average
Solventum (SOLV) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, SOLV broke through the 20-day moving average, which suggests a short-term bullish trend.
Solventum (SOLV) Recently Broke Out Above the 50-Day Moving Average
From a technical perspective, Solventum (SOLV) is looking like an interesting pick, as it just reached a key level of support. SOLV recently overtook the 50-day moving average, and this suggests a short-term bullish trend.
